SQZ Biotechnologies (NYSE:SQZ) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.51) by 17.65 percent. This is a 20 percent increase over losses of $(0.75) per share from the same period last year.
SQZ Biotechnologies (NYSE:SQZ) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.51) by 17.65 percent. This is a 20 percent increase over losses of $(0.75) per share from the same period last year.
Comments